@article{c0b896243eb042b5b3fc1bf8f2dfb154,
title = "Effects of CYP2C9 polymorphisms on phenprocoumon anticoagulation status [1] (multiple letters)",
keywords = "acenocoumarol, anticoagulant agent, cytochrome P450 2C9, phenprocoumon, warfarin, allele, anticoagulation, catalysis, dose response, drug clearance, drug hydroxylation, drug metabolism, genetic polymorphism, genotype, human, letter, priority journal, risk assessment, statistical significance, steady state",
author = "Mike Ufer and Tom Schalekamp and {De Boer}, Anthonius",
year = "2005",
month = apr,
day = "1",
doi = "10.1016/j.clpt.2005.01.012",
language = "English",
volume = "77",
pages = "335--336",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Wiley-Blackwell",
number = "4",
}